The most anticipated initial public offering filing in years arrived on October 26, 2026, yet it is legally incapable of stating the one number everyone is quoting. Anthropic, PBC submitted its Form S-1 registration statement to the Securities and Exchange Commission, officially signaling its intent to list on the Nasdaq Global Select Market under the ticker symbol ANT. While the document provides a granular look at the company’s financial architecture, it remains silent on the specific share count and price range that will ultimately define its market debut. This is not an act of evasion, but a standard feature of the regulatory process; the S-1 is a disclosure of business health and risk, not a pre-negotiated price tag.
What the filing does provide is a clear view of the company’s current financial standing. For the first half of 2026, Anthropic reported revenue of $16.3 billion against a net loss of $80.7 billion. For market observers, the headline loss requires careful parsing. The figure is largely driven by an increase in the value of convertible bonds, representing a non-cash mark rather than an operating bleed. By separating these accounting adjustments from the underlying business performance, the filing offers a window into the company’s scale that was previously obscured by its private status.
The silence regarding the offering price is where the market’s speculative machinery currently resides. Because the registration statement has been filed but has not yet become effective, no offers or sales are permitted. The pricing mechanism is a staged evolution. Following a confidential filing on June 1, 2026, the company is now operating on a ladder of private-market valuations that have escalated rapidly: a Series G round in February 2026 valued the company at roughly $380 billion, followed by a Series H round in May 2026 that reached a post-money valuation of $965 billion. These figures are historical markers, not current pricing.
Press expectations, which are not figures disclosed in the filing, have pushed the narrative significantly higher. Bloomberg has reported expectations that the IPO could match or exceed the $1.8 trillion valuation of SpaceX, while CNBC has noted investor sentiment circling the $2 trillion mark, a figure previously floated in September reporting. Reuters has suggested a potential capital raise of up to $100 billion. These projections, often citing a range of 22x to 30x revenue, are external market estimates. They reflect the intense demand for the asset, but they remain entirely detached from the formal S-1 document currently under review by the SEC.
The process from here is a structured march toward effectiveness. The company has named Goldman Sachs and Morgan Stanley as lead underwriters, though reports mentioning other institutions in the syndicate remain unconfirmed. The next phase involves a period of SEC review and subsequent amendments to the registration statement. It is only through these later amendments that the specific price range will be introduced, typically coinciding with the start of the roadshow marketing process. Press reports indicate that this marketing phase could begin as early as November 9, 2026, with a listing targeted for days before the November US midterms.
The current state of the filing provides the necessary transparency for potential investors to evaluate the business. However, the valuation remains a moving target, subject to the ongoing dialogue between the underwriters and the institutional buy-side during the upcoming roadshow. The market is not waiting for a number to be revealed in a static document; it is waiting for the price to be discovered through the mechanics of the offering itself.
As the SEC review proceeds, the focus remains on the transition from private-market benchmarks to public-market reality. The filing has brought the company a step closer to a historic offering, but the final valuation will only crystallize when the roadshow concludes and the shares are priced through later amendments to the registration statement.
